Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma (Q73497493)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 1997

Language	Label	Description	Also known as
English	Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma	scientific article published on 01 July 1997

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

head and neck carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

A A Abitbol

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K S Sridhar

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A A Lewin

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J G Schwade

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W Raub

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Wolfson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Gonzalez-Angulo

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Adessa

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W J Goodwin

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A M Markoe

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

0 references

publication date

1 July 1997

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

80

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

266-276

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Biologic basis for altered fractionation schemes.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Solid tumour models for the assessment of different treatment modalities: IV. the combined effects of radiation and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Stage III and localized stage IV breast cancer: irradiation alone vs irradiation plus surgery

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. A pilot study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

ASTRO plenary: interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Loss of local control with prolongation in radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Taxol as a radiation sensitizer: a flow cytometric study.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Chemical modifiers of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C266%3A%3AAID-CNCR15%3E3.0.CO%3B2-S

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19970715)80:2<266::AID-CNCR15>3.0.CO;2-S

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9217040%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73497493&oldid=1760152372"